These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 318218)

  • 21. Treatment of significant bacterial infections in adults with cefoxitin.
    Ribner BS; Billiard BS; Freimer EH
    Rev Infect Dis; 1979; 1(1):152-7. PubMed ID: 318216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of serious skin and soft tissue infections with ofloxacin administered by intravenous and oral route.
    Lentino JR; Augustinsky JB; Weber TM; Pachucki CT
    Chemotherapy; 1991; 37(1):70-6. PubMed ID: 2013245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous or intramuscular teicoplanin once daily for skin and soft-tissue infections.
    Edelstein HE; Oster SE; Chirurgi VA; Karp RA; Cassano KB; McCabe RE
    DICP; 1991 Sep; 25(9):914-8. PubMed ID: 1835223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
    Talan DA; Summanen PH; Finegold SM
    Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
    McCloskey RV
    Antimicrob Agents Chemother; 1977 Nov; 12(5):636-41. PubMed ID: 335968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with doxycycline in the treatment of surgical soft-tissue infections.
    Marks G; Mervine TB
    Curr Ther Res Clin Exp; 1974 May; 16(5):424-30. PubMed ID: 4209058
    [No Abstract]   [Full Text] [Related]  

  • 27. Cefoxitin therapy for bacterial endocarditis.
    Webb D; Thadepalli H; Bach V
    Rev Infect Dis; 1979; 1(1):170-4. PubMed ID: 318219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.
    Weigelt JA
    Adv Ther; 1994; 11(4):183-91. PubMed ID: 10150262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies of cefoxitin for the treatment of respiratory tract infections (author's transl)].
    Suetsugu S; Naito T; Ishikawa H; Umeda H; Suzuki K; Morise M; Sakai S; Shimokata K; Katayama T; Kobayashi T; Tsunekawa H; Nishimura M; Iwakura M; Nishiwaki K; Nomura Y; Yoshikawa K; Fujii K; Izumi S; Katoh T; Ito T; Hattori J; Yoshii S; Takeura S; Maeda F
    Jpn J Antibiot; 1982 Feb; 35(2):375-93. PubMed ID: 7087175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
    Greenberg RN; Kennedy DJ; Reilly PM; Luppen KL; Weinandt WJ; Bollinger MR; Aguirre F; Kodesch F; Saeed AM
    Antimicrob Agents Chemother; 1987 Feb; 31(2):151-5. PubMed ID: 3566245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellulitis: treatment with cefoxitin compared with multiple antibiotic therapy.
    Santos JI; Jacobson JA; Swensen P; Palmer WM
    Pediatrics; 1981 Jun; 67(6):887-90. PubMed ID: 7015265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of cefoxitin, a new semisynthetic cephamycin.
    Little PJ; Peddie BA
    N Z Med J; 1978 Jul; 88(616):46-9. PubMed ID: 279853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clindamycin treatment of osteomyelitis and septic arthritis in children.
    Feigin RD; Pickering LK; Anderson D; Keeney RE; Shackleford PG
    Pediatrics; 1975 Feb; 55(2):213-23. PubMed ID: 1118208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cefoxitin sodium therapy in anaerobic infections.
    Thadepalli H; Webb D; Roy I; Bach V
    J Antimicrob Chemother; 1978 Jul; 4(B):203-8. PubMed ID: 357387
    [No Abstract]   [Full Text] [Related]  

  • 36. Cefoxitin serum and uterine concentrations following a two-gram intramuscular dose.
    Hemsell DL; Birkett I; Reveley L; Bland JA
    Obstet Gynecol; 1982 Feb; 59(2):149-52. PubMed ID: 7078858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of serious obstetric and gynecologic infections with cefoxitin.
    Hager WD; McDaniel PS
    J Reprod Med; 1983 May; 28(5):337-40. PubMed ID: 6152988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
    Lami JL; Wilson SE; Hopkins JA
    Am Surg; 1991 Dec; 57(12):769-74. PubMed ID: 1746792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse reactions to parenteral lincomycin.
    Berry DD; Brouhard BH; Box QT
    Pediatrics; 1981 Mar; 67(3):389-91. PubMed ID: 7017577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.